X T L Biopharmaceuticals reported $714K in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Bioline Rx USD 39.8M 3.47M Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
X T L Biopharmaceuticals USD 714K 7.84M Jun/2025